Impact of a Technology Mediated Dance Intervention

Technology-mediated Dance: Impact on Psychossocial, Physical, and Cognitive Functions of the Old

This study aims to investigate whether a technology-mediated dance impacts on psychosocial, physical and cognitive functions of the old adults when compared to usual activities.

Study Overview

• Status: Completed
• Conditions: Older Adults Without Any Specific Clinical Condition
• Intervention / Treatment: Other: Dance mediated by tecnhology

Detailed Description

This study aims to investigate whether a technology-mediated dance impacts on psychosocial, physical, and cognitive functions of old adults when compared to usual activities. It will have two arms one of which will receive a dance mat and perform dance sessions for 8 weeks, while the other group will continue their usual activities. Participants will be assessed for psychosocial, physical, and cognitive aspects at baseline, end of the intervention, and at 3 months follow-up.

• Study Type: Interventional
• Enrollment (Actual): 70
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Portugal
  • Aveiro, Portugal
    • School of Health Sciences

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 65 years and older (Older Adult)
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• People living independently in the community
• 65 years old or older
• With no cognitive impairment defined based on the 6-item cognitive decline test [4]
• Independent at walking without walking aids
• Access to a personal computer and internet
• For older adults unable to use a computer, a patient or carer with digital literacy needs to be identified for the older adult to enter the study.

Exclusion Criteria:

• Reporting cardiovascular pathology that limits the performance of the dance or dizziness or imbalance prior to using the mat

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: Usual activities; This group will receive no intervention.
Experimental: DanceMove; This group will perform dance sessions mediated by technology (a dance mat and a web platform).	Other: Dance mediated by tecnhology; A web system and a dance mat are used to stimulate participants to perform dance activities for 8 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Gait velocity	Assessed using the gait velocity test, i.e., the velocity of gait when walking in a straight line for 4 meters; it is measured in meters per second.	Baseline
Gait velocity	Assessed using the gait velocity test, i.e., the velocity of gait when walking in a straight line for 4 meters; it is measured in meters per second.	After the intervention (8 weeks after baseline assessment)
Gait velocity	Assessed using the gait velocity test, i.e., the velocity of gait when walking in a straight line for 4 meters; it is measured in meters per second.	At 3 months follow up

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Balance	Balance will be assessed through the Functional Reach Test, which measures the ability of a person to reach forward without moving the feet; it is measured in cm.	Baseline
Balance	Balance will be assessed through the Functional Reach Test, which measures the ability of a person to reach forward without moving the feet; it is measured in cm.	After the intervention (8 weeks after baseline assessment)
Balance	Balance will be assessed through the Functional Reach Test, which measures the ability of a person to reach forward without moving the feet; it is measured in cm.	At 3 months follow up
Cognitive functioning	This will be measured using the Trail Making Test which is a paper-based test; score is given in seconds.	Baseline
Cognitive functioning	This will be measured using the Trail Making Test which is a paper-based test; score is given in seconds.	After the intervention (8 weeks after baseline assessment)
Cognitive functioning	This will be measured using the Trail Making Test which is a paper-based test; score is given in seconds.	At 3 months follow up
Pain intensity	Measured with a 100 mm Vertical Numeric Pain Rating Scale, anchored with 0 (no pain) and 100 (worst possible pain)	Baseline
Pain intensity	Measured with a 100 mm Vertical Numeric Pain Rating Scale, anchored with 0 (no pain) and 100 (worst possible pain)	After the intervention (8 weeks after baseline assessment)
Pain intensity	Measured with a 100 mm Vertical Numeric Pain Rating Scale, anchored with 0 (no pain) and 100 (worst possible pain)	At 3 months follow up
Quality of life	Measured using the WHOQOL-Bref (WHO Quality of Life questionnaire); scores range between 0 to 20 and higher scores indicate better quality of life	Baseline
Quality of life	Measured using the WHOQOL-Bref (WHO Quality of Life questionnaire); scores range between 0 to 20 and higher scores indicate better quality of life	After the intervention (8 weeks after baseline assessment)
Quality of life	Measured using the WHOQOL-Bref (WHO Quality of Life questionnaire); scores range between 0 to 20 and higher scores indicate better quality of life	At 3 months follow up
Health status	Measured using the EuroQoL EQ-5D; scores range from 5 to 25 and higher scores; indicate lower quality of life (note: according to the EuroQol Research Foundation, EQ-5D is not an abbreviation and is the correct term to use in print or verbally)	Baseline
Health status	Measured using the EuroQoL EQ-5D; scores range from 5 to 25 and higher scores; indicate lower quality of life (note: according to the EuroQol Research Foundation, EQ-5D is not an abbreviation and is the correct term to use in print or verbally)	After the intervention (8 weeks after baseline assessment)
Health status	Measured using the EuroQoL EQ-5D; scores range from 5 to 25 and higher scores; indicate lower quality of life (note: according to the EuroQol Research Foundation, EQ-5D is not an abbreviation and is the correct term to use in print or verbally)	At 3 months follow up
Self-efficacy	Measured using the Perceived Self-Efficacy Scale; scores vary between 10 and 40 and higher scores indicate higher self-efficacy	Baseline
Self-efficacy	Measured using the Perceived Self-Efficacy Scale; scores vary between 10 and 40 and higher scores indicate higher self-efficacy	After the intervention (8 weeks after baseline assessment)
Self-efficacy	Measured using the Perceived Self-Efficacy Scale; scores vary between 10 and 40 and higher scores indicate higher self-efficacy	At 3 months follow up
Loneliness	Measured using the University of California, Los Angeles, Loneliness Scale; scores vary between 4 and 28 and higher scores indicate higher loneliness	Baseline
Loneliness	Measured using the University of California, Los Angeles, Loneliness Scale; scores vary between 4 and 28 and higher scores indicate higher loneliness	After the intervention (8 weeks after baseline assessment)
Loneliness	Measured using the University of California, Los Angeles, Loneliness Scale; scores vary between 4 and 28 and higher scores indicate higher loneliness	At 3 months follow up
Social support	Measured with the Oslo Social Support Scale (OSSS-3) with Life Events Scale; score varies between 3 and 14 and higher scores indicate stronger social support	Baseline
Social support	Measured with the Oslo Social Support Scale (OSSS-3) with Life Events Scale; score varies between 3 and 14 and higher scores indicate stronger social support	After the intervention (8 weeks after baseline assessment)
Social support	Measured with the Oslo Social Support Scale (OSSS-3) with Life Events Scale; score varies between 3 and 14 and higher scores indicate stronger social support	At 3 months follow up

Collaborators and Investigators

• Sponsor: Aveiro University
• Investigators: Principal Investigator: Anabela Silva, School of Health Sciences, University of Aveiro

Study record dates

Study Major Dates

• Study Start (Actual): July 19, 2022
• Primary Completion (Actual): November 30, 2023
• Study Completion (Actual): November 30, 2023

Study Registration Dates

• First Submitted: July 14, 2022
• First Submitted That Met QC Criteria: July 14, 2022
• First Posted (Actual): July 15, 2022

Study Record Updates

• Last Update Posted (Estimated): February 6, 2024
• Last Update Submitted That Met QC Criteria: February 5, 2024
• Last Verified: February 1, 2024

More Information

Terms related to this study

• Other Study ID Numbers: DanceMove

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No